ArticleFrontiers in sleep2025
Case Report: REM sleep without atonia in an adult with pediatric acute-onset neuropsychiatric syndrome: a case study and mechanistic insights.
Article in Frontiers in sleep, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS) is an immune-mediated disorder marked by abrupt onset of obsessive-compulsive symptoms and a spectrum of neuropsychiatric and somatic features, including sleep disturbances. Although polysomnographic studies increasingly document REM Sleep Without Atonia (RSWA) in children with PANS, persistence of RSWA into adulthood remains unreported and poorly understood. Case presentation: We report a 20-year-old woman with a 5-year history of relapsing-remitting neuropsychiatric symptoms consistent with PANS, including obsessive-compulsive features, complex tics, anxiety, and sleep disruption. The onset was temporally associated with a viral illness and followed by recurrent exacerbations triggered by infections and psychosocial stressors. Polysomnography, conducted during an inter-episode baseline, revealed RSWA with reduced REM atonia and fragmented sleep architecture, despite the absence of REM sleep behavior disorder (RBD). At onset, clinical findings included motor incoordination and sensorimotor hypersensitivities. Past serological workup supported a post-infectious inflammatory phenotype. Discussion: This case expands current understanding of PANS by documenting persistent RSWA in an adult patient, suggesting chronic disruption of REM-regulating neurocircuits. Mechanistically, we explore how basal ganglia autoimmunity, dopaminergic dysregulation, and hypothalamic orexin imbalance may converge to impair REM atonia. Emerging literature is consistent with RSWA as a state or trait marker of central neuroinflammation in neuroimmune conditions such as PANS. These findings underscore the diagnostic and pathophysiological relevance of sleep phenotyping in neuroinflammatory syndromes and call for longitudinal evaluation of sleep physiology across the disease course. Conclusion: RSWA may represent an under-recognized manifestation of chronic neuroimmune dysfunction in PANS. Its persistence into adulthood suggests long-term dysregulation of REM sleep circuitry and invites further investigation into the role of orexin and basal ganglia-mediated inhibition in neuroimmune disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.